{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
HAIR REANIMATOR LEAVE IN SERUM WITH KERATIN ARGAN ISATIS AND BLACK CUMIN OILS HORSE FORCE by Zeldis-farma, Ooo
(2015)
Source URL:
First approved in 2015
Source:
HAIR REANIMATOR LEAVE IN SERUM WITH KERATIN ARGAN ISATIS AND BLACK CUMIN OILS HORSE FORCE by Zeldis-farma, Ooo
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M020
(2015)
Source URL:
First approved in 2015
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2015)
Source URL:
First approved in 2015
Source:
Sallys Box Friendly Collagen Eye Patch by Imine Co., Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Phytopecia Hair Boosting by Phytos Co., Ltd.
(2015)
Source URL:
First approved in 2015
Source:
Phytopecia Hair Boosting by Phytos Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03857425: Phase 4 Interventional Completed Gastritis
(2019)
Source URL:
First approved in 2015
Source:
BIOVITA by ILDONG PHARMACEUTICAL CO., LTD.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2015
Source:
V.S. Power / Vacsu Power (Dynamic and Powerful 99 year life) by Mercylignt
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2015
Source:
Edge by Sensuous Pty Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2015)
Source URL:
First approved in 2015
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2015
Source:
PYUNG GANG ATO SOON by Pyung Gang Oriental Medical Clinic
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Chavita 3 by RUBIMED AG
(2015)
Source URL:
First approved in 2015
Source:
Chavita 3 by RUBIMED AG
Source URL:
Class:
STRUCTURALLY DIVERSE